InVivo Therapeutics and The Miami Project to Cure Paralysis form strategic research collaboration
Thursday, May 5, 2011
InVivo Therapeutics, a company focused on the development of technologies for the treatment of spinal cord injuries (SCI), and The University of Miami Miller School of Medicine’s Miami Project to Cure Paralysis, a spinal cord injury research center, have entered into a strategic research collaboration for the development of novel SCI treatments.
The collaboration will evaluate InVivo’s biopolymer devices synergistically combined with cellular therapies, including The Miami Project’s Schwann cell technologies.
Key components of the research collaboration agreement include in vitro and in vivo studies with combinations of biomaterials, Schwann cells and other cellular therapies and drugs; joint ownership of resulting intellectual property; and the right of first offer for InVivo to license and commercialize on a worldwide exclusive basis.